Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
McKinsey
QuintilesIMS
Baxter
Boehringer Ingelheim
AstraZeneca
Julphar
Medtronic
Citi

Generated: January 20, 2018

DrugPatentWatch Database Preview

Armodafinil - Generic Drug Details

« Back to Dashboard

What are the generic sources for armodafinil and what is the scope of armodafinil patent protection?

Armodafinil
is the generic ingredient in two branded drugs marketed by Lupin Ltd, Mylan Pharms Inc, Natco Pharma Ltd, Watson Labs Inc, and Cephalon, and is included in five NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for armodafinil. Fourteen suppliers are listed for this compound. There are four tentative approvals for this compound.
Tentative approvals for ARMODAFINIL
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe50MGTABLET;ORAL
➤ Subscribe➤ Subscribe250MGTABLET;ORAL
➤ Subscribe➤ Subscribe200MGTABLET;ORAL

US Patents and Regulatory Information for armodafinil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Natco Pharma Ltd ARMODAFINIL armodafinil TABLET;ORAL 202768-002 Nov 28, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cephalon NUVIGIL armodafinil TABLET;ORAL 021875-005 Mar 26, 2009 AB RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Natco Pharma Ltd ARMODAFINIL armodafinil TABLET;ORAL 202768-001 Nov 28, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lupin Ltd ARMODAFINIL armodafinil TABLET;ORAL 200751-004 Nov 28, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Natco Pharma Ltd ARMODAFINIL armodafinil TABLET;ORAL 202768-003 Nov 28, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Inc ARMODAFINIL armodafinil TABLET;ORAL 200156-004 Aug 29, 2012 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cephalon NUVIGIL armodafinil TABLET;ORAL 021875-004 Jun 15, 2007 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Mylan Pharms Inc ARMODAFINIL armodafinil TABLET;ORAL 200043-003 Jun 1, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cephalon NUVIGIL armodafinil TABLET;ORAL 021875-001 Jun 15, 2007 AB RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Cephalon NUVIGIL armodafinil TABLET;ORAL 021875-004 Jun 15, 2007 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for armodafinil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cephalon NUVIGIL armodafinil TABLET;ORAL 021875-002 Mar 26, 2009 ➤ Subscribe ➤ Subscribe
Cephalon NUVIGIL armodafinil TABLET;ORAL 021875-001 Jun 15, 2007 ➤ Subscribe ➤ Subscribe
Cephalon NUVIGIL armodafinil TABLET;ORAL 021875-005 Mar 26, 2009 ➤ Subscribe ➤ Subscribe
Cephalon NUVIGIL armodafinil TABLET;ORAL 021875-005 Mar 26, 2009 ➤ Subscribe ➤ Subscribe
Cephalon NUVIGIL armodafinil TABLET;ORAL 021875-001 Jun 15, 2007 ➤ Subscribe ➤ Subscribe
Cephalon NUVIGIL armodafinil TABLET;ORAL 021875-002 Mar 26, 2009 ➤ Subscribe ➤ Subscribe
Cephalon NUVIGIL armodafinil TABLET;ORAL 021875-004 Jun 15, 2007 ➤ Subscribe ➤ Subscribe
Cephalon NUVIGIL armodafinil TABLET;ORAL 021875-003 Jun 15, 2007 ➤ Subscribe ➤ Subscribe
Cephalon NUVIGIL armodafinil TABLET;ORAL 021875-004 Jun 15, 2007 ➤ Subscribe ➤ Subscribe
Cephalon NUVIGIL armodafinil TABLET;ORAL 021875-003 Jun 15, 2007 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Farmers Insurance
Medtronic
Colorcon
Argus Health
Chinese Patent Office
Harvard Business School
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot